Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
mFOLFOX7 Neoadjuvant Chemotherapy for Resectable Advanced Gastric Cancer
NCT00591045Phase 2Unknown
- Sponsor
- Peking University
- Start
- Jan 2008
- Primary completion
- Dec 2012
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, fluorouracil, folinic acid in gastric cancer (GC), sponsored by Peking University. Status: unknown.
02
Drugs
oxaliplatinfluorouracilfolinic acid
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00591045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00591045.